Security key
04216R102
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)
CUSIP: 04216R102
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 1,351,550
- Total 13F value
- $6,609,000
- Share change
- +29,390
- SEC-reported price per share
- $4.89
- Number of holders
- 15
- Value change
- +$136,417
- Number of buys
- 7
- Number of sells
- 5
- Shares outstanding
- 67,070,688
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
15
Top holders
10
ARMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Armata Pharmaceuticals, Inc. SEC filings
Armata Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04216R102
Recent filing periods:
Ownership snapshot
Top reported holders of ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BANK OF AMERICA CORP /DE/
Disclosed value leader
BANK OF AMERICA CORP /DE/
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 0.95%
Showing 1-6 of 15 holder rows.
Quick read
BANK OF AMERICA CORP /DE/ leads the comparable SEC ownership view at 0.95%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BANK OF AMERICA CORP /DE/'s linked filing trail.
Comparable ownership
Top 5
BANK OF AMERICA CORP /DE/
0.95%
VANGUARD GROUP INC
0.39%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
0.17%
EDGEWOOD MANAGEMENT LLC
0.15%
RENAISSANCE TECHNOLOGIES LLC
0.13%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.95%
|
$3,474,000
633,944 shares
|
— | 31 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
0.39%
|
$1,440,000
262,750 shares
|
— | 31 Dec 2021 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.17%
|
$623,000
113,682 shares
|
— | 31 Dec 2021 |
| EDGEWOOD MANAGEMENT LLC |
13F
Company
|
0.15%
|
$548,000
100,000 shares
|
— | 31 Dec 2021 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.13%
|
$465,000
84,796 shares
|
— | 31 Dec 2021 |
| SYNOVUS FINANCIAL CORP |
13F
Company
|
0.07%
|
$263,000
48,035 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
1,351,550
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
15
Q1 2022 holders
15
Holder diff
0
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend